Testing the therapeutic potential of doxycycline in a drosophila melanogaster model of Alzheimer disease
Therapies for Alzheimer disease that reduce the production of pathogenic amyloid beta (A beta) peptides have been associated with a range of unwanted effects. For this reason, alternative strategies that promote the clearance of the peptide by preventing its aggregation and deposition in the brain h...
| Autor principal: | |
|---|---|
| Outros Autores: | , , |
| Formato: | article |
| Idioma: | eng |
| Publicado em: |
2021
|
| Assuntos: | |
| Texto completo: | http://hdl.handle.net/10400.22/18579 |
| País: | Portugal |
| Oai: | oai:recipp.ipp.pt:10400.22/18579 |